Efectividad del ácido ursodesoxicólico versus fenobarbital para el tratamiento de la colestasis en prematuros. Ensayo clínico cruzado

Romero Maldonado, Silvia; Godínez Téllez, Noemí Caritina; Yescas-Buendía, Gabino; Fernández-Carrocera, Luis Alberto; Echániz Avilés, María Olga Leticia; Reyna Ríos, Edna Rocely.
Bol. méd. Hosp. Infant. Méx ; 67(5): 422-429, sep.-oct. 2010. tab
Artículo en Español | LILACS | ID: lil-701056

Documentos relacionados

  1. [Hyperthyroidism and cholestasis: a case report].
  2. One-step versus two-step distal self-expandable metal stent placement: A multicenter prospective randomized trial.
  3. [Neonatal cholestasis: the viewpoint of the pediatrician].
  4. Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis.
  5. The effects of gestational age on neonatal cholestasis: A retrospective cohort study.
  6. Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.
  7. [The diagnosis of cholestasis: lipoprotein X (LP-X) (author's transl)].
  8. Lipid emulsions for parenterally fed term and late preterm infants.
  9. Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis.
  10. Effect of ursodeoxycholic acid after self-expandable metal stent placement in malignant distal biliary obstruction: a propensity score-matched cohort analysis.